Ana M Aparicio

26PUBLICATIONS
185CO-AUTHORS
Molecular targetsCardiology (incl. cardiovascular diseases)Cancer therapy (excl. chemotherapy and radiation therapy)Neurology and neuromuscular diseasesPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Sep 29, 2026
Clinical and Molecular Profiles of Treatment-Emergent Small Cell Neuroendocrine Prostate Cancers in the Era of Intensified Systemic Therapies.

|Nov 07, 2025
Evaluating Clinical Tools to Monitor Cardiovascular Risk in Men With Prostate Cancer Receiving Hormone Therapy.

Neha Venkatesh, Pankaj Kumar Chauhan, Sagar S Mukhida

|Oct 11, 2025
Integrating systemic therapy and metastasis-directed therapy in oligometastatic hormone-sensitive prostate cancer.

Xiaolei Shi, Jarey H Wang, Brian F Chapin

|Aug 27, 2025
Racial and Ethnic Disparities Along the Treatment Cascade Among Medicare Fee-for-Service Beneficiaries With Metastatic Breast, Colorectal, Lung, and Prostate Cancers.

John K Lin, Jiangong Niu, Sharon H Giordano

|Jul 21, 2025
Safety and Efficacy of Tarlatamab in Patients with Neuroendocrine Prostate Cancer: Results from the Phase 1b DeLLpro-300 Study.

Rahul Aggarwal, Sylvie Rottey, Alice Bernard-Tessier

|May 13, 2025
CHD1 loss reprograms SREBP2-driven cholesterol synthesis to fuel androgen-responsive growth and castration resistance in SPOP-mutated prostate tumors.

Feiyu Chen, Haoyan Li, Yin Wang

Pageof 5

Frequent Collaborators

6 joint publications

Christopher Logothetis

6 joint publications

Sumit K Subudhi

5 joint publications

Andrew W Hahn

4 joint publications

Amado Zurita-Saavedra